Valneva to Participate in the World s First COVID-19 Vaccine Booster Trial in the UK streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
DORSET hospitals will become some of the first in the world to provide a third ‘booster’ Covid vaccine, the health secretary has announced. Volunteers from Dorset will be able to receive a third booster Covid jab through a new clinical trial in Dorset, Southampton and Portsmouth. The Cov-Boost study, backed by £19.3 million of government funding through the Vaccines Taskforce, will be run at University Hospital Southampton, University Hospitals Dorset and the Portsmouth Research Hub (Portsmouth Hospitals), and is being led by University Hospital Southampton. It will be the first in the world to provide vital data on the impact of a third dose on patients’ immune responses.
About VLA2001
VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe. It is intended for active immunization of at-risk populations to prevent carriage and symptomatic infection with COVID-19 during the ongoing pandemic and potentially later for routine vaccination including addressing new variants. VLA2001 may also be suited for boosting, as repeat booster vaccinations have been shown to work well with whole virus inactivated vaccines. VLA2001 is produced on Valneva’s established Vero-cell platform, leveraging the manufacturing technology for Valneva’s licensed Japanese encephalitis vaccine, IXIARO
®. VLA2001 consists of inactivated whole virus particles of SARS-CoV-2 with high S-protein density, in combination with two adjuvants, alum and CpG 1018. This adjuvant combination has consistently induced higher antibody levels in preclinical experiments than alum-only formulations and shown a shift of the
Matt Hancock announces vaccine booster trial to stop winter surge
Thousands of people are set to get a third covid shot as the government tries to fight a winter outbreak
Updated
The video will auto-play soon8Cancel
Play now
Thousands of people will get a coronavirus booster shot in a new trial announced by Health Secretary Matt Hancock. The Cov-Boost study, led by University Hospital Southampton NHS Foundation Trust, will trial seven vaccines in the hope that a a third shot will help fight a winter surge of Covid-19. The Health Secretary said initial results of the trial are expected in September - reports Mirror Online.
Updated 5 hours ago
Thousands of volunteers set to receive a third jab in world-first test of seven vaccines.
WPA Pool via Getty Images
Thousands of volunteers will receive a Covid vaccine booster in a new “world-first” clinical trial, Matt Hancock has announced.
The health secretary said seven vaccines will be tested to see the impact of a third dose on patients’ immune responses.
It will include a total of 2,886 patients and participants are to begin being vaccinated from early June. The initial findings are expected in September.
“The UK vaccination programme has been a phenomenal national effort, with seven in 10 UK adults now having had their first Covid-19 jab,” Hancock said.